| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |